Sionna Therapeutics (SION) Common Equity (2024 - 2026)
Sionna Therapeutics (SION) posted Common Equity of $288.2 million for Q1 2026, down 6.07% sequentially from $306.8 million in Q4 2025, and down 18.07% YoY from $351.8 million in Q1 2025.
Sionna Therapeutics (SION) Common Equity (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Common Equity for 3 years, with the latest figure at $288.2 million in Q1 2026.
- Quarterly Common Equity fell 18.07% year-over-year to $288.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.2 million (down 18.07% YoY) and the FY2025 annual result came in at $306.8 million, up 287.42% from the prior year.
- Common Equity eased to $288.2 million in Q1 2026 per SION's latest filing, from $306.8 million in the prior quarter.
- Over five years, Common Equity peaked at $351.8 million in Q1 2025 and troughed at -$163.7 million in Q4 2024.
- A 3-year average of $114.8 million and a median of $288.2 million in 2026 frame the typical range for Common Equity.
- The sharpest annual moves came in 2025 and 2026: Common Equity jumped 379.0% in 2025, then retreated 18.07% in 2026.
- Over 3 years, Common Equity stood at -$163.7 million in 2024, then surged by 287.42% to $306.8 million in 2025, then slipped by 6.07% to $288.2 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $288.2 million, $306.8 million, and $321.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | 265.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 265.78 Mn |
| Mar 31, 2026 | 288.21 Mn |
| Dec 31, 2025 | 306.83 Mn |
| Sep 30, 2025 | 321.67 Mn |
| Jun 30, 2025 | 336.43 Mn |
| Mar 31, 2025 | 351.77 Mn |
| Dec 31, 2024 | -163.71 Mn |
| Sep 30, 2024 | -148.55 Mn |
| Jun 30, 2024 | -133.77 Mn |
| Mar 31, 2024 | -126.08 Mn |